KeyCorp Issues Positive Forecast for STERIS (NYSE:STE) Stock Price

Posted by George Bondi on Nov 7th, 2026

STERIS (NYSE:STE – Free Report) had its price target increased by KeyCorp from $269.00 to $284.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock.

A number of other equities research analysts have also issued reports on STE. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. UBS Group decreased their price target on shares of STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Piper Sandler reaffirmed an “overweight” rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $276.33.

Read Our Latest Analysis on STE

STERIS Trading Down 0.7%

STERIS stock traded down $1.78 during mid-day trading on Friday, hitting $252.34. The stock had a trading volume of 1,389,562 shares, compared to its average volume of 706,132. The stock has a 50-day simple moving average of $220.58 and a two-hundred day simple moving average of $224.71. The stock has a market capitalization of $24.60 billion, a PE ratio of 29.93 and a beta of 0.86. STERIS has a 12 month low of $195.14 and a 12 month high of $269.44. The company has a current ratio of 1.91, a quick ratio of 1.35 and a debt-to-equity ratio of 0.23.

STERIS (NYSE:STE – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The medical equipment provider reported $2.94 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.26. STERIS had a return on equity of 14.34% and a net margin of 13.34%. The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company earned $2.47 earnings per share. The company’s revenue was up 8.8% on a year-over-year basis. As a group, sell-side analysts forecast that STERIS will post 11.17 EPS for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be paid a $0.69 dividend. The ex-dividend date is Tuesday, November 17th. This represents a $2.76 annualized dividend and a dividend yield of 1.1%. STERIS’s dividend payout ratio (DPR) is presently 32.74%.

Insider Transactions at STERIS

In other STERIS news, Director Mohsen Sohi sold 4,058 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the completion of the transaction, the director owned 24,305 shares of the company’s stock, valued at approximately $5,730,632.90. The trade was a 14.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.12% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC raised its holdings in STERIS by 0.7% in the 2nd quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock valued at $1,710,000 after buying an additional 56 shares during the last quarter. Taylor Frigon Capital Management LLC increased its position in STERIS by 0.9% during the 3rd quarter. Taylor Frigon Capital Management LLC now owns 6,505 shares of the medical equipment provider’s stock valued at $1,366,000 after purchasing an additional 58 shares during the period. Strengthening Families & Communities LLC raised its holdings in STERIS by 0.6% during the 3rd quarter. Strengthening Families & Communities LLC now owns 10,884 shares of the medical equipment provider’s stock worth $2,286,000 after purchasing an additional 61 shares during the last quarter. Mather Group LLC. lifted its position in shares of STERIS by 14.4% in the 3rd quarter. Mather Group LLC. now owns 565 shares of the medical equipment provider’s stock worth $119,000 after purchasing an additional 71 shares during the period. Finally, Community Financial Services Group LLC boosted its stake in shares of STERIS by 50.0% in the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 72 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Company Profile

(Get Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures.

The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.